Theriva Biologics, Inc. - TOVX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$431K
QoQ value delta ($000)
+$167K (+63.26%)
Implied price effect (QoQ)
-4.77%
Shares
Total shares
2,221,008
QoQ shares delta
+925,500 (+71.44%)
Total shares held by funds (by quarter)

Market chart (TOVX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 22 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
GEODE CAPITAL MANAGEMENT, LLC 88 450,263 0.0%
VANGUARD GROUP INC 53 255,727 0.0%
Virtu Financial LLC 50 253,218 0.0%
VANGUARD FIDUCIARY TRUST CO 47 241,780 0.0%
UBS Group AG 44 225,624 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 37 192,404 0.0%
JANE STREET GROUP, LLC 34 177,034 0.0%
Ikarian Capital, LLC 21 112,076 0.0%
TWO SIGMA SECURITIES, LLC 20 105,241 0.0%
XTX Topco Ltd 18 94,620 0.0%
BOOTHBAY FUND MANAGEMENT, LLC 5 27,646 0.0%
MORGAN STANLEY 4 23,602 0.0%
StoneX Group Inc. 4 22,280 0.0%
TWO SIGMA INVESTMENTS, LP 3 15,441 0.0%
SCHWARZ DYGOS WHEELER INVESTMENT ADVISORS LLC 2 15,000 0.0%
BlackRock, Inc. 1 7,504 0.0%
DANSKE BANK A/S 0 1 0.0%
CITIGROUP INC 0 1,391 0.0%
IFP Advisors, Inc 0 11 0.0%
OSAIC HOLDINGS, INC. 0 8 0.0%
SBI Securities Co., Ltd. 0 131 0.0%
NFSG Corp 0 5 0.0%
ROYAL BANK OF CANADA 0 1 0.0%